Endocardial endothelium is a key determinant of force-frequency relationship in rat ventricular myocardium

Journal of Applied Physiology

Volumn 115, Issue 3, 2013, Pages 383-393

  Shen, Xiaoxu ^a,b,c   Tan, Zhen ^c   Zhong, Xin ^c   Tian, Ye ^c   Wang, Xian ^a   Yu, Bo ^c   Ramirez Correa, Genaro ^b   Murphy, Anne ^b   Gabrielson, Kathleen ^b   Paolocci, Nazareno ^b   Gao, Wei Dong ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac excitation contraction coupling; Endocardial endothelium; Endothelin 1; Force frequency relationship; Isoproterenol; Rat myocardium

Indexed keywords

CALCIUM; CARDIOTONIC AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; ISOPRENALINE; PROTEIN KINASE C;

ACTION POTENTIAL; ANIMAL; ARTICLE; CALCIUM SIGNALING; CARDIAC EXCITATION-CONTRACTION COUPLING; ELECTROSTIMULATION; ENDOCARDIAL ENDOTHELIUM; EXCITATION CONTRACTION COUPLING; FORCE-FREQUENCY RELATIONSHIP; HEART; HEART CONTRACTION; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; RAT; RAT MYOCARDIUM; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; VASCULAR ENDOTHELIUM;

CARDIAC EXCITATION-CONTRACTION COUPLING; ENDOCARDIAL ENDOTHELIUM; ENDOTHELIN-1; FORCE-FREQUENCY RELATIONSHIP; ISOPROTERENOL; RAT MYOCARDIUM;

ACTION POTENTIALS; ANIMALS; CALCIUM; CALCIUM SIGNALING; CARDIOTONIC AGENTS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTRIC STIMULATION; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EXCITATION CONTRACTION COUPLING; HEART; HEART RATE; HEART VENTRICLES; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PROTEIN KINASE C; RATS; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK;

EID: 84881455354     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01415.2012     Document Type: Article

References (64)

1. Antoons G, Mubagwa K, Nevelsteen I, Sipido KR. Mechanisms underlying the frequency dependence of contraction and [Ca(2+)](i) transients in mouse ventricular myocytes. J Physiol 543: 889-898, 2002.
2. 2+]i and cross-bridge kinetics. J Physiol 476: 487-500, 1994.
3. 2+ pump inhibitor, in rabbit and rat ventricular muscle. Br J Pharmacol 117: 258-267, 1996.
4. Bauersachs J, Schafer A. Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2: 115-124, 2004.
5. Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacol Rep 60: 119-126, 2008.
6. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
7. Bluhm WF, Kranias EG, Dillmann WH, Meyer M. Phospholamban: a major determinant of the cardiac force-frequency relationship. Am J Physiol Heart Circ Physiol 278: H249-H255, 2000.
8. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 36: 1187-1205, 2004.
9. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83: 59-115, 2003.
10. Brutsaert DL, Meulemans AL, Sipido KR, Sys SU. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 62: 358-366, 1988.
11. 2+ signaling in contractile regulation induced by crosstalk between endothelin-1 and norepinephrine in dog ventricular myocardium. Circ Res 92: 1024-1032, 2003.
12. Cotton JM, Kearney MT, MacCarthy PA, Grocott-Mason RM, Mc-Clean DR, Heymes C, Richardson PJ, Shah AM. Effects of nitric oxide synthase inhibition on basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation 104: 2318-2323, 2001.
13. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contraction in failing cardiac muscle. Eur J Pharmacol 553: 222-228, 2006.
14. Dai T, Tian Y, Tocchetti CG, Katori T, Murphy AM, Kass DA, Paolocci N, Gao WD. Nitroxyl increases force development in rat cardiac muscle. J Physiol 580: 951-960, 2007.
15. Daniels MC, Fedida D, Lamont C, ter Keurs HE. Role of the sarcolemma in triggered propagated contractions in rat cardiac trabeculae. Circ Res 68: 1408-1421, 1991.
16. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560, 1996.
17. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
18. De Keulenaer GW, Doggen K, Lemmens K. The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy. Circ Res 106: 35-46.
19. Edwards AS, Scott JD. A-kinase anchoring proteins: protein kinase A and beyond. Curr Opin Cell Biol 12: 217-221, 2000.
20. Eisner DA, Choi HS, Diaz ME, O'Neill SC, Trafford AW. Integrative analysis of calcium cycling in cardiac muscle. Circ Res 87: 1087-1094, 2000.
21. 2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells. Jpn Heart J 39: 1-44, 1998.
22. Endoh M. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. Eur J Pharmacol 500: 73-86, 2004.
23. Ezzaher A, el Houda Bouanani N, Crozatier B. Force-frequency relations and response to ryanodine in failing rabbit hearts. Am J Physiol Heart Circ Physiol 263: H1710-H1715, 1992.
24. 2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 57: 20-27, 2003.
25. 2+ sensitivity in intact versus skinned rat ventricular muscle. Circ Res 74: 408-415, 1994.
26. 2+-dependent proteolysis? Circ Res 78: 455-465, 1996.
27. Gao WD, Perez NG, Marban E. Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol 507: 175-184, 1998.
28. 2+ transients in HL-1 cardiomyocytes. J Biomed Sci 19: 59.
29. Hashimoto K, Perez NG, Kusuoka H, Baker DL, Periasamy M, Marban E. Frequency-dependent changes in calcium cycling and contractile activation in SERCA2a transgenic mice. Basic Res Cardiol 95: 144-151, 2000.
30. Hayes JS, Brunton LL, Mayer SE. Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1. J Biol Chem 255: 5113-5119, 1980.
31. Hool LC. Protein kinase C isozyme selective peptides-a current view of what they tell us about location and function of isozymes in the heart. Curr Pharm Des 11: 549-559, 2005.
32. Janssen PM, Stull LB, Marban E. Myofilament properties comprise the rate-limiting step for cardiac relaxation at body temperature in the rat. Am J Physiol Heart Circ Physiol 282: H499-H507, 2002.
33. Kelso EJ, McDermott BJ, Silke B, Spiers JP. Endothelin(A) receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium. J Pharmacol Exp Ther 294: 1047-1052, 2000.
34. Koss KL, Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. Circ Res 79: 1059-1063, 1996.
35. 2+]i-frequency relationships in rat ventricular trabeculae at physiological frequencies. Am J Physiol Heart Circ Physiol 276: H9-H18, 1999.
36. Lemmens K, Segers VF, Demolder M, De Keulenaer GW. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem 281: 19469-19477, 2006.
37. Li K, Rouleau JL, Calderone A, Andries JL, Brutsaert DL. Effects of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles. Circ Res 72: 768-777, 1993.
38. Li K, Stewart DJ, Rouleau JL. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Role of endocardial endothelium. Circ Res 69: 301-312, 1991.
39. Maier LS, Bers DM. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J Mol Cell Cardiol 34: 919-939, 2002.
40. 2+-content in isolated rat and rabbit myocardium. J Mol Cell Cardiol 32: 2249-2258, 2000.
41. McClellan G, Weisberg A, Rose D, Winegrad S. Endothelial cell storage and release of endothelin as a cardioregulatory mechanism. Circ Res 75: 85-96, 1994.
42. Mebazaa A, Mayoux E, Maeda K, Martin LD, Lakatta EG, Robotham JL, Shah AM. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol Heart Circ Physiol 265: H1841-H1846, 1993.
43. Meulemans AL, Andries LJ, Brutsaert DL. Does endocardial endothelium mediate positive inotropic response to angiotensin I and angiotensin II? Circ Res 66: 1591-1601, 1990.
44. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 93: 1223-1229, 1996.
45. Mohan P, Brutsaert DL, Sys SU. Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins. Cardiovasc Res 29: 637-640, 1995.
46. Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81: III21-III32, 1990.
47. Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, Rockman HA. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 117: 2445-2458, 2007.
48. Ono K, Tsujimoto G, Sakamoto A, Eto K, Masaki T, Ozaki Y, Satake M. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 370: 301-304, 1994.
49. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
50. Penna C, Rastaldo R, Mancardi D, Cappello S, Pagliaro P, Westerhof N, Losano G. Effect of endothelins on the cardiovascular system. J Cardiovasc Med (Hagerstown) 7: 645-652, 2006.
51. Perez-Schindler J, Philp A, Baar K, Hernandez-Cascales J. Regulation of contractility and metabolic signaling by the beta2-adrenergic receptor in rat ventricular muscle. Life Sci 88: 892-897, 2011.
52. Qi XL, Stewart DJ, Gosselin H, Azad A, Picard P, Andries L, Sys SU, Brutsaert DL, Rouleau JL. Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts. Circulation 100: 1338-1345, 1999.
53. Rossman EI, Petre RE, Chaudhary KW, Piacentino V, 3rd Janssen PM, Gaughan JP, Houser SR, Margulies KB. Abnormal frequencydependent responses represent the pathophysiologic signature of contractile failure in human myocardium. J Mol Cell Cardiol 36: 33-42, 2004.
54. Schafer A, Fraccarollo D, Pfortsch S, Loch E, Neuser J, Vogt C, Bauersachs J. Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure. Basic Res Cardiol 106: 485-494, 2011.
55. 2+ management in cardiac myocytes. Ann NY Acad Sci 1015: 28-38, 2004.
56. Smith JA, Shah AM, Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol 439: 1-14, 1991.
57. Stemmer P, Akera T. Concealed positive force-frequency relationships in rat and mouse cardiac muscle revealed by ryanodine. Am J Physiol Heart Circ Physiol 251: H1106-H1110, 1986.
58. Sugden PH. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35: 871-886, 2003.
59. Sys SU, De Keulenaer GW, Brutsaert DL. Physiopharmacological evaluation of myocardial performance: how to study modulation by cardiac endothelium and related humoral factors? Cardiovasc Res 39: 136-147, 1998.
60. 2+-frequency relationships: similarities to dog and human. Cardiovasc Res 61: 77-86, 2004.
61. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84: 1020-1031, 1999.
62. 2+ responsiveness in aequorin-loaded ferret myocardium. Circ Res 70: 754-760, 1992.
63. 2+ responsiveness in aequorin-loaded ferret myocardium. Circ Res 69: 582-589, 1991.
64. Xiao RP, Avdonin P, Zhou YY, Cheng H, Akhter SA, Eschenhagen T, Lefkowitz RJ, Koch WJ, Lakatta EG. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res 84: 43-52, 1999.